Stemson Therapeutics Secures $7.5M in Seed Financing
Stemson Therapeutics, a San Diego, CA-based maker of a therapeutic solution to cure hair loss, raised $7.5m in seed financing. Stemson aims to restore human hair growth with a novel approach using the patient’s own cells to generate new hair follicles. The seed funding supports the preclinical development of Stemson’s Induced Pluripotent Stem Cell (iPSC) based technology, which is capable of producing the cell types required to initiate hair follicle growth. Stemson received approval in the United States of its cornerstone Human Induced Pluripotent Stem Cell (iPSC) method patent licensed exclusively from the Sanford Burnham Prebys Medical Discovery Institute. The patent secures foundational methods using iPSC cell therapy to grow hair.